Current Ratio of Nabriva Therapeutics plc from 30 Sep 2017 to 30 Jun 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nabriva Therapeutics plc quarterly Current Ratio in % history and change rate from 30 Sep 2017 to 30 Jun 2023.
  • Nabriva Therapeutics plc Current Ratio for the quarter ending 30 Jun 2023 was 109%, a 71% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Nabriva Therapeutics plc Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2023 109% -262% -71% 30 Jun 2023
Q1 2023 162% -261% -62% 31 Mar 2023
Q4 2022 234% -196% -46% 31 Dec 2022
Q3 2022 311% -110% -26% 30 Sep 2022
Q2 2022 371% -54% -13% 30 Jun 2022
Q1 2022 424% -5.6% -1.3% 31 Mar 2022
Q4 2021 429% +25% +6.2% 31 Dec 2021
Q3 2021 421% -66% -14% 30 Sep 2021
Q2 2021 425% -86% -17% 30 Jun 2021
Q1 2021 429% -84% -16% 31 Mar 2021
Q4 2020 404% -158% -28% 31 Dec 2020
Q3 2020 487% -92% -16% 30 Sep 2020
Q2 2020 511% -104% -17% 30 Jun 2020
Q1 2020 514% -137% -21% 31 Mar 2020
Q4 2019 562% -163% -23% 31 Dec 2019
Q3 2019 579% -182% -24% 30 Sep 2019
Q2 2019 615% -141% -19% 30 Jun 2019
Q1 2019 650% +3.4% +0.53% 31 Mar 2019
Q4 2018 725% +161% +28% 31 Dec 2018
Q3 2018 761% +224% +42% 30 Sep 2018
Q2 2018 756% 30 Jun 2018
Q1 2018 647% 31 Mar 2018
Q4 2017 565% 31 Dec 2017
Q3 2017 537% 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.